ADMA BIOLOGICS, INC. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by ADMA Biologics, Inc. on May 29, 2019. The Company is a Delaware corporation incorporated in 2019, with its principal executive offices located in Ramsey, New Jersey. Its common stock trades on the Nasdaq Capital Market under the symbol "ADMA". The filing is designated as an "Other Event" (Item 8.01) and does not cover a specific financial reporting period such as a quarter or fiscal year.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely to announce upcoming corporate presentations and does not contain financial statements or performance data.
Material Changes
No material changes to financial position or operations are reported in this filing. The document contains no comparative data versus prior periods.
Guidance, Outlook, and Management Commentary
Management has scheduled corporate overview presentations for June 2019. Adam Grossman, President and CEO, and Brian Lenz, Executive Vice President and CFO, will present at the following events:
- Jefferies 2019 Healthcare Conference: June 6, 2019, at 9:00 AM ET in New York, NY.
- Raymond James Life Sciences and MedTech Conference: June 19, 2019, at 10:20 AM ET in New York, NY.
These presentations will be webcast live via the Company's Investor Relations website. The filing references Exhibit 99.1 for a discussion of forward-looking statements and associated risks.
Investor Verification Checklist
- Verify the content of the press release dated May 29, 2019 (Exhibit 99.1) for specific details on the upcoming presentations.
- Review the Company's website (www.admabiologics.com) to access the live webcasts of the June 2019 conferences.
- Consult the most recent 10-Q or 10-K filing for actual financial metrics, as this 8-K contains no financial data.
- Review the risk factors associated with forward-looking statements as referenced in Exhibit 99.1.